StockData
BioHarvest Sciences Inc. logo

BioHarvest Sciences Inc. (BHST) stock

BHSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 31, 2026Score 5/30
$1.23+0.01 (+0.82%)

Close on Nov 18, 2026Market cap $27.88MP/E –Yield –

BioHarvest Sciences operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

For fiscal 2025 it was -$5.58M.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$5.58M–
FY2024Dec 31, 2024-$6.99M–
FY2023Dec 31, 2023-$9.97M–

More BioHarvest Sciences figures

See a number that looks wrong?